SN1
SHORT NOTE
5M
★ High-yield
Define Immune Thrombocytopenic Purpura. Describe its clinical features, investigations, diagnosis and management.
Definition
- Immune (idiopathic) thrombocytopenic purpura (ITP) is an acquired disorder of immune-mediated platelet destruction (antibody-coated platelets removed by the spleen), causing isolated thrombocytopenia.
- It is the commonest cause of acute thrombocytopenia in a well child.
Clinical Features
- Often follows a viral infection 1–3 weeks earlier; typically a well child aged 2–6 years.
- Sudden petechiae, purpura and bruising; mucosal bleeding (epistaxis, gum bleeding).
- No hepatosplenomegaly or lymphadenopathy (their presence suggests another diagnosis, e.g. Leukaemia).
Investigations
- Isolated thrombocytopenia with a normal haemoglobin and white-cell count; large (young) platelets on the smear.
- Bone marrow (if atypical) shows normal or increased megakaryocytes.
- It is largely a diagnosis of exclusion.
Management
- Acute childhood ITP is usually self-limiting — most recover within weeks to months.
- Observation for mild disease (skin signs only); avoid trauma, contact sports and antiplatelet drugs.
- For significant bleeding or very low counts — corticosteroids, IV immunoglobulin, or anti-D.
- Chronic ITP (> 12 months) — further options (thrombopoietin agonists, rituximab, splenectomy).
Differential Diagnosis
- Leukaemia (look for anaemia, neutropenia, blasts, organomegaly), aplastic anaemia.
- Other causes of thrombocytopenia — infections (dengue), drugs, hypersplenism, SLE.
Complications & Prognosis
- Serious bleeding (including rare intracranial haemorrhage) is the main risk with very low counts.
- Most childhood ITP resolves spontaneously within 6–12 months with an excellent prognosis; a minority become chronic.
When to Investigate Further / Suspect Another Cause
- Abnormal haemoglobin or white cells, organomegaly or lymphadenopathy → bone marrow to exclude leukaemia/aplasia.
- Atypical age, chronic course, or failure to respond to standard therapy.
All questions in Haematology & Oncology
- Q1Define Iron Deficiency Anaemia. Describe its aetiology, pathophysiology, clinical features and investigations. ★
- Q2Define Beta-Thalassaemia Major. Describe its pathophysiology, clinical features, investigations and management. ★
- Q3Define Acute Lymphoblastic Leukaemia. Describe its clinical features, investigations, management and prognosis. ★
- Q4Define Haemophilia. Describe its clinical features, investigations, management and complications. ★
- Q5Define Approach to a Child with Anaemia. Describe its classification, investigations and management. ★
- SN1Define Immune Thrombocytopenic Purpura. Describe its clinical features, investigations, diagnosis and management. ★
- SN2Define Sickle Cell Disease. Describe its clinical features, investigations, management and types. ★
- SN3Define Megaloblastic Anaemia. Describe its causes, clinical features, investigations and diagnosis.
- SN4Define Aplastic Anaemia. Describe its causes, clinical features, investigations and complications.
- SN5Define G6PD Deficiency. Describe its clinical features, investigations, pathophysiology and management.
- SN6Define Neuroblastoma. Describe its clinical features, investigations and prognosis.
- SN7Define Hodgkin Lymphoma. Describe its classification, aetiology, clinical features and investigations.